Daiwa Securities Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-60
| Closed | – | – | 1343 |
|
|
2023
Q3 | $0 | Hold |
60
| – | – | ﹤0.01% | 1304 |
|
|
2023
Q2 | $0 | Sell |
60
-3,263
| -98% | – | ﹤0.01% | 1325 |
|
|
2023
Q1 | $33K | Buy |
3,323
+641
| +24% | +$6.37K | ﹤0.01% | 1052 |
|
|
2022
Q4 | $50K | Sell |
2,682
-674
| -20% | -$12.6K | ﹤0.01% | 1033 |
|
|
2022
Q3 | $69K | Sell |
3,356
-946
| -22% | -$19.5K | ﹤0.01% | 1029 |
|
|
2022
Q2 | $89K | Buy |
4,302
+2,557
| +147% | +$52.9K | ﹤0.01% | 1030 |
|
|
2022
Q1 | $75K | Buy |
1,745
+529
| +44% | +$22.7K | ﹤0.01% | 1066 |
|
|
2021
Q4 | $73K | Buy |
1,216
+584
| +92% | +$35.1K | ﹤0.01% | 1059 |
|
|
2021
Q3 | $54K | Buy |
632
+598
| +1,759% | +$51.1K | ﹤0.01% | 1044 |
|
|
2021
Q2 | $4K | Hold |
34
| – | – | ﹤0.01% | 1084 |
|
|
2021
Q1 | $4K | Buy |
34
+7
| +26% | +$824 | ﹤0.01% | 1089 |
|
|
2020
Q4 | $3K | Sell |
27
-48
| -64% | -$5.33K | ﹤0.01% | 1082 |
|
|
2020
Q3 | $10K | Buy |
75
+28
| +60% | +$3.73K | ﹤0.01% | 1029 |
|
|
2020
Q2 | $4K | Hold |
47
| – | – | ﹤0.01% | 1105 |
|
|
2020
Q1 | $4K | Buy |
47
+5
| +12% | +$426 | ﹤0.01% | 1106 |
|
|
2019
Q4 | $2K | Hold |
42
| – | – | ﹤0.01% | 1149 |
|
|
2019
Q3 | $1K | Hold |
42
| – | – | ﹤0.01% | 1138 |
|
|
2019
Q2 | $1K | Hold |
42
| – | – | ﹤0.01% | 1159 |
|
|
2019
Q1 | $2K | Hold |
42
| – | – | ﹤0.01% | 1117 |
|
|
2018
Q4 | $2K | Hold |
42
| – | – | ﹤0.01% | 1091 |
|
|
2018
Q3 | $3K | Hold |
42
| – | – | ﹤0.01% | 1089 |
|
|
2018
Q2 | $2K | Hold |
42
| – | – | ﹤0.01% | 1125 |
|
|
2018
Q1 | $2K | Buy |
+42
| New | +$2K | ﹤0.01% | 1117 |
|